Spero Therapeutics Company
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections.
Employee Number:
11-50
Funding Status:
IPO
Headquarters:
Cambridge, Massachusetts, United States
Technology:
Biologics
Estimated Revenue:
$1M to $10M
Founded Date:
2013
Industry:
PharmTech